In addition, genes that were disrupted (FHIT, FLCN, and RASGEF1A) or occurred within a relevant TAD structure coinciding with the breakpoints of the novel RCC‐associated rearrangements reported here were also assessed. This evidence concerns the gene RASGEF1A and renal cell carcinoma.